Marksans Pharma completes acquisition of manufacturing site from Tevapharm India
Marksans will continue to supply existing products until the end of 2023 to Teva's affiliates, ensuring high-quality standards
Marksans will continue to supply existing products until the end of 2023 to Teva's affiliates, ensuring high-quality standards
Study efficacy measures will include the expression of dystrophin protein and motor function.
Marksans' OTC Famotidine Tablets USP are acid reducers
The product will be manufactured at the plant of Bell, Sons & Co. (Druggists) Ltd. located at Gifford House, Slaidburn Crescent, Southport, UK
OrbiMed's exercise of warrant conversion will further strengthen the company's net cash position to over Rs.650 crores.
Over 30 years of deep life sciences industry experience with a wide range of expertise in corporate governance, capital markets, licensing and strategic collaborations
The company has reported total income of Rs. 450.26 crores during the period ended June 30, 2022.
The US FDA had conducted an inspection of Alkem Laboratories Limited's manufacturing facility located at St. Louis, USA.
Access Healthcare for Medical Products (Access Healthcare) provides pharmaceutical companies with innovative marketing and sales solutions in the MENA (Middle East & North Africa) region
PSCI, a global non-profit organization, works with its members to ensure a positive environment that can improve global healthcare supply chains
Subscribe To Our Newsletter & Stay Updated